Vertex Pharmaceuticals: double bottom and relaunch from base

Fresh buy signal on Vertex Pharmaceuticals: the stock built a double bottom in the 421 area with a 9% intermediate rebound, and the weekly MACD has just turned to a bullish crossover with price above the Ichimoku cloud. IQS at 60 out of 100, medium signal strength at 50 out of 100: a structurally grounded entry, to be followed carefully through the confirmation week.